Publicidad

Pharmaceutical validation

Pavisara
25 de Sep de 2018
Publicidad

Más contenido relacionado

Publicidad

Pharmaceutical validation

  1. Ms. PAVITHRA .S M.Pharm(SEM-I) Dept. of Pharmaceutics PRESENTED BY… GUIDED BY… Prf. K.KARTHICK Asso.Professor, Dept. of Pharmaceutics. Subject: Modern Pharmaceutics
  2.  Validation is the action of proving that any procedure, process, equipment, method, material or activities actually leads to the expected results which produce a quality product.  Validation is “Establishing document evidence that provides a high degree of assurance that a specific process will consistently produce a product meeting its pre-determined specifications and quality attributes”.
  3.  Need for Validation: ◦ To obtain consistent, reliable and accurate data. ◦ To get assurance of quality product. ◦ To improve customer satisfaction. ◦ Customer mandated. ◦ Product liability. ◦ To control production cost. ◦ For the development of the next generation. ◦ Safety. ◦ Act as a proof in decision making.
  4.  Changes in the established methods  New method developed for a particular problem.  Established method used in different laboratories, different equipment or different staff.  Out of control situations within internal quality assurance.  Demonstration of equivalence between two methods (eg: A rapid new test against a standard method).
  5.  It is an integral part of quality assurance.  It involves controlling the critical steps of a system, which results in output of repeatable attributes eg: a validated tablet manufacturing process assures attributes of product consistency from batch to batch and a validated sterilization cycle assures the sterility of the product.  Validation of a system indicates that system has been subject to such a scrutiny, that results of a system can be guaranteed.  Validation itself does not improve processes but confirms consistent output.
  6.  Validation increases the knowledge of the process which is being performed.  Assures the repeatability or reproducibility of the process.  Assures the fluency of the production  Reduces the risk of manufacturing problems such as rejection and reworking.  Reduces the expenses caused in the failures in production.  Decreases the risk of failing in GMP or regulatory non- compliance  Decreases the expenses of everyday production even though validation itself will create expenses.
  7.  Reduces down time  Improves efficiency and productivity be optimization.  Improved employee awareness of processes.  Reduces testing of in-process or finished goods  Provides a source to meet regulatory requirements.  Reduces the chances of product recall from market.
  8.  The validation work requires considerable resources such as: • Time • Finance • Human(experts)
  9.  Qualification and Validation are essentially the same  The term qualification is normally used for equipment and utensils, and validation is used for systems and processes.
  10.  Manufacturers should organise and plan validation in a manner that will ensure product quality, safety and efficacy throughout its life cycle.  The scope and extent of qualification and validation should be based on risk management principles.  Statistical calculations should be applied in order to provide scientific evidence that the process is appropriately validated.  It should be done in accordance with predetermined protocols and the results should be documented.  It should be an appropriate and effective quality system ensuring the organisation and management of validation.
  11.  Senior management should ensure that there are sufficient resources to perform validation in a timely manner. Management and persons responsible for quality assurance should be actively involved in the process and authorization of protocols and reports.  Personnel with appropriate qualification and experience should be responsible for validation.  There should be a specific programme or schedule to support planning and execution of validation activities.  Validation should be performed in a structured way according to the documented protocols and procedures.
  12. Experience Planning Resource Understanding and Communication Training Instrument’s SOP and Methodologies Validation Master plan Data Analysis Validation report
  13.  Documents associated with qualification and validation include: ◦ Validation master plan(VMP) ◦ Standard operating procedures(SOP) ◦ Specification ◦ Protocols and reports ◦ Risk assessment outcomes ◦ Process flow charts ◦ Operator manuals ◦ Training records ◦ Calibration procedures and records ◦ Sampling plans ◦ Testing plans and methods ◦ Statistical methods and results ◦ History of qualification and validation ◦ Plan for ensuring review of validation status ◦ Plan for ensuring maintaining a validated state.
  14.  Validation documents always requested in regulatory audits  Documentation is retained forever.  Documents reviewed long after people are gone (it should stand alone).  FDA auditors often focus on documentation- validation documents often requested ahead of audit.
  15.  Written for the reader- US vs Europe  Objective: understanding  Clarity – much more important than brevity  Stand- alone document  Potential for review in 10+ years  Author/ Managemnt not available for explanation.  Spelling and grammar should be correct ◦ Need good writers ◦ Simple sentences ◦ Simple words
  16.  VMP is a document , which presents overview of the entire validation operational structure, content and planning.  It should contain data on following chapters: ◦ Validation policy of the company, general description of the scope of those operations covered by VMP, location and schedule. ◦ Organisation and structure of validation activities, personnel responsibility for each activity such as protocols of individual projects, validation work, report and document preparation and their control, approval of validation protocols and reports in all stages of validation process, tracking system for review, training needs in support of validation. ◦ Rationale behind any challenge or ‘worst case’ situation. ◦ Specific requirement of the plant/ processes that need extra attention may be briefly outlined. ◦ List of products, processes and systems to be validated. ◦ Installation and qualification requirement for new equipment.
  17. ◦ Planning and scheduling i.e. estimate of staffing, equipment and specific requirements to complete the validation, time plan of project with detailed planning of subprojects. ◦ Change control- a statement of company’s commitment to controlling critical changes to materials, facilities, equipment or processes, analytical method. The VMP should be a summary document and should therefore be brief, concise. A VMP helps : • Management to know what validation programme involves with respect to time, people and money and to understand the necessity for the programme. • Members of validation team to know their tasks and responsibilities. • GMP inspectors- to understand company’s approaches to validation and the setup an organisation of all validation activities
  18.  It should be prepared and the conclusion drawn at each stage stated.  The final conclusion should reflect whether protocol requirements were met.  The evaluation should include an assessment of the planned calibration and maintenance programs for the equipment and instrument to maintain the validated conditions.  All process monitoring and control procedures, required to routinely ensure the validated conditions are maintained, should be reported.  The analysis should be signed by the authorised officer of organisation who were members of team establishing the protocol and who have appropriate expertise in the area assigned to them.  The overall approval of the study should be authorised by the head of quality control department and head of validation team.
  19.  Aim and purpose of the study  References to protocols  List of raw materials used  List of equipment used  Critical process steps studied  Results of data collected  Acceptance criteria evaluation  Analysis of result  Validation recommendation  Attachments (Batch records.)
  20.  Technical areas must be aware that their documents are critical to validation throughout the product lifecycle.  Process capability design is done to determine: ◦ The number and relative importance of critical process parameters that influence process outputs. ◦ The numerical values or ranges for each of the critical process parameters that result in acceptable process output.  If the process capability is properly defined, the process should result into output of consistent attributes when operated within the defined limits of critical process parameters.
  21.  Critical quality attributes are : ◦ Chemical purity ◦ Impurity profile ◦ Polymorphic forms ◦ Physical characterization(particle size, bulk density, etc) ◦ Moisture content ◦ Microbial quality
  22.  It is designed to verify that all established limits of the critical process parameters are valid and that satisfactory products can be produced even under the ‘worst case’ conditions.  It represents the actual studies or trials conducted to show: ◦ That all systems, subsystems or unit operations of a manufacturing process perform as intended ◦ That all critical parameters operate within their assigned control limits. ◦ That such studies and trials which form the basis of the process capability design and testing are verifiable and certifiable through proper documentation.
  23.  It requires frequent review of all process-related documents, including validation audit reports to ensure that there has been no changes, deviations, failures, modifications to the production process and that all the SOPs have been followed, including change control procedures.
  24. START DEFINE THE PROCESS OR THE SYSTEM System meets the needs of the process? Qualify the system System meets requirements? Qualify process Continued Validation Redesign NO NO YES YES
  25. The major types of validation are:  PROCESS VALIDATION  CLEANING VALIDATION  EQUIPMENT VALIDATION  VALIDATION OF ANALYTICAL METHODS
  26.  As per FDA Nov 2008 “the collection of data from the process design stage throughout production, which establish scientific evidence that the product is capable of consistently delivering quality products”.  Process validation life cycle Stage 1: process design Stage 2: process qualification Stage 3:continued process verification
  27.  Each type represent a different pathway to concluding that a manufacture process is in state of control. ◦ PROSPECTIVE VALIDATION: Validation is completed prior to the manufacture of finished product that is intended for sale. ◦ CONCURRENT VALIDATION: When prospective validation is not possible, it may be necessary to validate process during the routine production. ◦ RETROSPECTIVE VALIDATION: Processes that have been in use for sometime without any significant changes may be also be validated according to an approved protocol. ◦ REVALIDATION: It is performed when some changes are introduced in a system.
  28.  It is usually undertaken whenever a new formula, process and facility need to be validated before routine pharmaceutical production starts. Eg: switching to new filter medium, leak testing of lyophiliser.  It is also usually employed when sufficient historical data is either unavailaible or insufficient and, inprocess and final product testing is inadequate to ensure high degree of confidence for product quality characteristics and reproducibility. Eg: a sterile solution filled on new equipment should only be released after a media fill validation.  FDA guidelines on pre-approval inspection, associated with NDA/ ANDA submission, added a new dimension to this type of validation.
  29.  FDA is seeking evidence that the manufacturing process is validated before it allows a product to enter the market for sale.  FDA favours prospective validation for high degree of confidence and minimal risk, as it ensures process to be under control and effective prior to manufacture or release of the product.  Higher degree of confidence is associated with higher cost of production, therefore a due consideration must b given to FDA preference and cost to benefit analysis.
  30.  Concurrent validation is appropriate when: ◦ It is not possible to complete a validation programme before routine manufacturing starts and it is known in advance that finished product will be for sale. Eg: during the transference ot process to contract manufacturer. ◦ It is more appropriate to validation a process during routine production due to well understanding of process. Eg:change in tablet shape or strength. ◦ Extensive testing and monitoring ensures the desired quality characteristics of product with high degree of confidence but doesnot provide a degree of assurance that subsequent batches processed under the same condition and parameter will attain same quality attributes. ◦ Due to the limited acceptability of prospective and retrospective validation, the concept of concurrent validation under the paragraph “Acceptability of product testing” in validation process guidelines have been included by FDA.
  31.  There are so many processes in use in many companies that have not undergone a formally documented validation process.  Validation of these processes is possible, provided sufficient historical data is available to provide documentary evidence that various processes are considerably stable.  This type of validation is preferred because of cost effectiveness  It is acceptable only for well established processes and where critical quality attributes and critical process parameters have been identified and documented.  In general. Datas from 10 to 30 consecutive batches should be examined to assess process consistency, the review should include any batches that failed to meet specifcations.  Any discripancies in the historical data may be excluded provide there is sufficient evidence that the failure was caued by isolated occurences. Eg: employee error.  Sources: batch documents, control charts, maintainance logbooks, records of personnel changes, process capability studies, finished product data, trend cards and storage stability results.
  32.  It is a repetition of the validation process or a specific part of it.  It is either performed periodically to ascertain the process or to incorporate some changes in the procedure.  1.Changes to validated system: A system once validated, continues to remain validated as long as all conditions and control parameters are not changed. Therefore a change control quality assurance system must be established which requires revalidation whenever there are conditions which impact changes in product characteristics . Eg: changes in the test procedure, raw materials, packaging system, plant site, facilities, equipments, processing steps, batch size, etc.
  33.  2.Periodic Revalidation: some manufacturers revalidate certain systems at pre-established periodic intervals, even when no change is believed to occur.  The need for revalidation is very useful in case of sterile processes when compared to non-sterile processes.  3.Change control classification: The change-control program should provide a classification scheme to evaluate changes in raw/packaging materials, manufacturing site/location, batch size, manufacturing equipments and production process, product attributes (changes in formulation, strength).  The classification procedure should be used in determining the level of testing, validation and documentation is needed to justify changes to a validated process.  Changes should be categorised as minor and major changes (depending upon the nature an extent of the changes)
  34.  A minor change is defined as the one that is unlikely to have a detectable impact on the critical attributes of the product.  A major change is the one that would likely, significantly affect the critical quality attributes of the product.  FDA in its scale up and post approval changes (SUPAC) guidelines classifies the various levels of changes depending upon the impact of changes on quality and performance of product  Level 1 changes: changes that are unlikely to have any detectable impact on formulation quality and performance.  Level 2 changes: changes that could have a significant impact on formulation quality and performance.  Level 3 changes: changes that are likely to have significant impact on formulation quality and performance.
  35.  Equipment validation starts from the decision to bring a piece of new equipment to the organisation and continues till the decommissioning of equipment at the end of useful life.  It goes through the three following phases: ◦ Pre-purchase or Pre-qualification phase – vendor specification, design qualification. ◦ Post-purchase or Qualification phase- installation, operational & performance qualification. ◦ Routine operation or Ongoing evaluation phase.
  36. Identify needs Design Qualification User requirement IQ, PQ, OQ Review and Approval Operation SOP Decommission Calibration and performance verification Maintenance Commission protocol Site Preparation Justification PRE PURCHASE POST PURCHASE ROUTINE OPERATION
  37.  Usually an operating department will require the purchase of a piece of equipment.  The rationale to bring a new piece of equipment should be well founded.  The benefits of acquiring the equipment, such as increasing productivity, meeting a specific need, or enhancing the capability should outweigh the expenditure of valuable and limited resources required to acquire the equipment and support its operation.  The operating department should establish the requirements in order to start a project.  The user should first decide on the basic functional requirement to define a type of equipment required to fulfil their needs.  A more detailed operational requirement can then be defined based on the functional requirements.  All these should be recorded in the user requirement document.
  38.  Initially various units available in the market should be taken at a glance.  The extent of resources and funds to accomplish the task should also be given due consideration .  The least expensive equipment may not be the best investment.  The most expensive may not be the appropriate instrument for operation.  Many of the functionality of the equipment system may not be required at all for the organization.  A consideration must also be given to the general background of the final user.  Simplicity is beauty and not all users are ready to tackle the complicated operations due to time constraints and training.
  39.  Although technical and economic factors have a major bearing on the selection of the vendor, no final decision should be made before analysing each prospective vendor’s capabilities in each of these areas.  vendor’s specifications are: ◦ The vendors previous experience in implemeting similar projects. ◦ The vendor’s financial stability ◦ The vendor’s guarantee of installation, training, start up support and after sales support, ◦ The level of training offered by the vendor ◦ Delivery times ◦ The vendor’s familiarity with regulatory requirements of the equipment. ◦ The vendor’s documentation and support of testing ◦ Experience of current users. ◦ Acceptance criteria and operational limit should be clearly understood by the vendor.
  40.  It outlines the key feature of the system designed to address the user requirements, regulatory complaince and selection rationale of the particular supplier.  Caution should be taken when putting together a design qualification since it will have major impact on installation, operation and performance qualifications.  The more functions thhat are specified in the DQ, the more work have to included in the installation, operation and performance qualification process.  The compliance of the basic design with the user requirement and regulatory requirement should be demonstrated and documented.
  41. SITE PREPARATION:  Careful planning is required to ensure that the necessary preparations to house the new equipment in the organization are completed.  Insufficient site preparations can cause major inconvenience and long delays in the installation process.  It is the wastage of money and time to have engineer show up in premises but not able to do anything due to lack of site preparation.  It is a common mistake to under estimate the effort and time required for site preparation.
  42.  Physical dimension of the equipment and accessories: It must be made sure that there is enough space to accommodate the equipment and accessories and the bench is strong enough to support the instrument.  Suitable operating environment for the equipment  Utilities  Health and Safety requirements
  43.  Instrument qualification is required to establish the functional capabilities and reliability of the system for its intended use.  The instrument post purchase qualification can be divided into three stages: ◦ Installation qualification ◦ Operation qualification ◦ Performance qualification.
  44.  IQ simple means, “is it correctly installed?’’  This is ensured through appropriate tests, related documents and records that equipment and ancillary system have been correctly commissioned, and are in confirmity with installation specification, equipment manuals schematics and engineering drawing.  It further consists of documented verifications that all key aspects of equipment are in working condition and have been properly installed in accordance with the manufacturer’s specification and placed in an environment suitable for its intended use.  IQ means the documentary evidence to prove that the premises, supporting utilities and the equipment have been built and installed in compliance with their design specifications.
  45.  1.PREVENTATIVE MAINTENANCE: The IQ should document that the equipment is enrolled in a preventive maintenance program to assure that the system continues to operate properly and no component of the system becomes inoperable due to wear and tear.  2.EQUIPMENT INFORMATION AND SUPPLIER INSTRUMENTS: The IQ should document equipment information including manufacturing agency, model number, and the serial number and verify that the information complies with the purchase orders and user requirements,
  46.  In addition, verification of equipment compliance with regulatory requirement should be performed.  Supplier’s working and operating instructions, maintenance requirements, calibration requirements and cleaning including sanitation and sterilisation requirement for the equipment should be collected and correlated.  3.CALIBRATION: The IQ should document that specific devices contained with the equipment have been calibrated to traceable standards.  documentation should include date on which calibration was performed and when calibration is due.
  47.  The test required to calibrate the equipment, the acceptance criteria and frequency of each test should be included in the calibration section of the SOPs. INSTRUMENT FEATURES CALIBRATION RECORD SHEET DESCRIPTION: 1. IDENTIFICATION NO: 2. MODEL NO: 3. SERIAL NO: 4. CAPACITY: 5. LOCATION: 6. DIMENSIONS: 7. PURPOSE: CALIBRATION INFORMATION: 1. CALIBRATION FREQUENCY 2. CALIBRATION NO: 3. CALIBRATION SOP NO AND TITLE: 4. CALIBRATION LIMITS: 5. UTILISATION RANGE: MAX:…….. MIN:………… Compiled by:….. Date……….
  48.  4. VERIFICATION OF COMPONENTS AND EQUIPMENT: Once the equipment reaches the owner’s plant, a parts list should be reviewed. This is to verify that all the parts against shipping and purchase order have been found acceptable.  5.SOPs : The IQ should document all SOPs pertaining to the approved equipment and its installation place. Applicable SOPs may include preventative maintenance, calibration, operation, document archival, and equipment logbook usage.  6.UTILITIES AND ENVIRONMENTAL CONDTIONS: The IQ should document the manufacturer’s specification for required utilities anfd verify that appropriate utilities are available for the system. Eg: electricity, steam, vaccum, heating, ventilation and air conditioning(HVAC)
  49.  OQ is a series of tests that measures the performance capability of the equipment.  OQ focuses on the equipment, rather than demonstrating performance capabilities relating to producing a particular product.  The process should establish that the equipment or system modules operate as intended, or capable of consistent operation within established specification.  All testing equipments must be and all the methodologies used to perform the OQ test must be validated.
  50.  All documents to support the testing equipment calibration should be included in the qualification report .  OQ must be performed via an established and accepted protocol  The proper operation will be verified by performing the test functions specified in the protocol.  The OQ testing should describe all aspects of the testing in detail.  The plans for OQ should identify the studies to be undertaken on the critical variables, the sequence of those studies and measuring equipment to be used and acceptance criteria to met.  SOPs and draft cleaning procedures are issued and approved after the completion of successful OQ.
  51.  PQ is defined as the process to verify that the system is repeatable and consistently producing a quality product.  PQ should follow an authorised protocol, may include the following: ◦ Tests using production materials that have been developed from the specialist knowledge of the process and how the equipment or system is intended to deliver its performance characteristics. ◦ Studies utilising production materials to include a condition or set of conditions encompassing upper and lower operating limits.
  52.  After the instrument is qualified and has been transferred to the operating department , SOPs must be strictly followed for operation, maintenance and calibration of equipment.  USAGE AND SERVICE RECORD: Good usage and service record for the equipment must be maintained through a logbook. Such a record is required for the GMP purposes, further it facilities the notification to the user in case of system failure.  CALIBRATION RECORD: It must be maintained for each equipment , stating information about date of calibration test done, name and signature of responsible person who performed calibration.
  53.  Each instrument must have calibration sticker with information related to the status of the syste, when the calibration was performed, who did the calibration, and the next calibration date .  CONSIDERATIONS: ◦ Responsibility of personnel involved in the calibration. ◦ Frequency of calibration for each type of instrument. ◦ Review and approval of calibration date ◦ Procedure of issue of calibration sticker ◦ Documentation requirement of the calibration and record keeping. ◦ Remedial action in event of calibration failure ◦ Procedure to notify users and obtain impact assessment in case of calibration failure.
  54. THANK YOU ALL
Publicidad